What does CUSIP 221015100 represent in this 13F holders report?

CUSIP 221015100 is the security identifier for CRVS - Corvus Pharmaceuticals, Inc. - COMMON STOCK used to aggregate holder disclosures.

How many institutions held CRVS - Corvus Pharmaceuticals, Inc. - COMMON STOCK in Q3 2023?

52 institutional investors reported CRVS - Corvus Pharmaceuticals, Inc. - COMMON STOCK for Q3 2023. Use the holders table for investor-level position and value details.

Corvus Pharmaceuticals, Inc. - COMMON STOCK (CRVS)

CUSIP: 221015100

Q3 2023 13F Holders as of 30 Sep 2023

Security type / class: Equity / COMMON STOCK
Total 13F shares: 19,186,334
Total 13F value: $28,011,450
Share change: -305,661
Put/Call ratio: 147%
SEC-reported price per share: $1.46
Number of holders: 52
Value change: -$1,230,958
Number of buys: 25
Number of sells: 21
Shares outstanding: 84,416,811

Security key

221015100

Report period

Q3 2023

Institutions

Top holders

CRVS full security history Ownership snapshot Full 13F holder table Newer quarter: Q3 2026 Corvus Pharmaceuticals, Inc. SEC filings Corvus Pharmaceuticals, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 221015100

Newer quarter: Q3 2026

Recent filing periods:

Q3 2026

Ownership snapshot

Top reported holders of CRVS - Corvus Pharmaceuticals, Inc. - COMMON STOCK (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

ADAMS STREET PARTNERS LLC

Disclosed value leader

ORBIMED ADVISORS LLC

Comparable rows

0/15

Latest evidence

30 Jun 2023

13F 3/4/5 Highest disclosed value: $15,900,968 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

ORBIMED ADVISORS LLC has the largest disclosed position value at $15.9M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens ORBIMED ADVISORS LLC's linked filing trail.

Disclosed position value Top 5

ADAMS STREET PARTNERS LLC $7.5M

EcoR1 Capital, LLC $64.1K

ORBIMED ADVISORS LLC $15.9M

SAMLYN CAPITAL, LLC $4.82M

BVF INC/IL $3.14M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
ADAMS STREET PARTNERS LLC	13F 3/4/5 Company · 10%+ Owner 13F 3/4/5	— mixed-class rows	$7,501,161 3,275,616 shares	—	30 Jun 2023
EcoR1 Capital, LLC	3/4/5 10%+ Owner 3/4/5	— denominator unverified	$64,051 81,077 shares	—	30 Sep 2021
ORBIMED ADVISORS LLC	13F Company 13F	— denominator unverified	$15,900,968 6,943,654 shares	—	30 Jun 2023
SAMLYN CAPITAL, LLC	13F Company 13F	— denominator unverified	$4,822,580 2,105,930 shares	—	30 Jun 2023
BVF INC/IL	13F Company 13F	— denominator unverified	$3,139,469 1,370,947 shares	—	30 Jun 2023
VANGUARD GROUP INC	13F Company 13F	— denominator unverified	$2,979,805 1,301,225 shares	—	30 Jun 2023

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

19,186,334

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2023 vs Q2 2023 Across Filers

Q2 2023 holders

Q3 2023 holders

Holder diff

Investor	Q2 2023 Shares	Q3 2023 Shares	Share Diff	Share Chg %	Q2 2023 value	Q3 2023 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend